AI boosts kidney drug: personalized dosing aims to double remission
NCT ID NCT06341205
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 35 times
Summary
This study tests whether an artificial intelligence program can help doctors give the right dose of the drug rituximab to people with a kidney disease called membranous nephropathy. The disease causes the immune system to attack the kidneys, and rituximab helps calm that attack. However, some patients lose the drug in their urine, making it less effective. The AI will predict who is at risk for low drug levels and suggest extra doses early on. The goal is to see if this personalized approach leads to more patients achieving remission (less protein in urine and better kidney function) after 6 months. About 120 adults with active disease will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEMBRANOUS NEPHROPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AP-HM - Hôpital de la Conception
RECRUITINGMarseille, France
Contact
-
AP-HP - Hôpital Européen Georges Pompidou
NOT_YET_RECRUITINGParis, France
Contact
-
AP-HP - Hôpital H. Mondor
RECRUITINGCréteil, France
Contact
-
AP-HP - Hôpital Necker
NOT_YET_RECRUITINGParis, France
Contact
-
CH de Valenciennes
NOT_YET_RECRUITINGValenciennes, France
Contact
-
CHRU de TOURS - Hôpital Bretonneau
RECRUITINGTours, France
Contact
-
CHU de BESANCON
RECRUITINGBesançon, France
Contact
-
CHU de BORDEAUX - Hôpital Pellegrin
RECRUITINGBordeaux, France
Contact
-
CHU de CAEN
RECRUITINGCaen, France
Contact
-
CHU de NICE
RECRUITINGNice, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHU de Nîmes - Hôpital CAREMEAU
RECRUITINGNîmes, France
Contact
-
CHU de TOULOUSE - Hôpital Rangueil
RECRUITINGToulouse, France
Contact
-
HCL - Hôpital E. Herriot
RECRUITINGLyon, France
Contact
Conditions
Explore the condition pages connected to this study.